XML 27 R18.htm IDEA: XBRL DOCUMENT v3.23.3

Revenue Concentration	6 Months Ended
	Mar. 31, 2023
Risks and Uncertainties [Abstract]
REVENUE CONCENTRATION	12. REVENUE CONCENTRATION For the three months ended March 31, 2023, the Company derived revenue of $12.6 million from two customers, with such customers accounting for 16% and 11% of the Company’s total revenue, respectively. For the three months ended March 31, 2022, the Company derived revenue of $11.8 million from two customers, with such customers accounting for 20%, and 15% of the Company’s total revenue, respectively. For the six months ended March 31, 2023, the Company derived revenue of $27.5 million from two customers, with each such customer accounting for 15% of the Company’s total revenue. For the six months ended March 31, 2022, the Company derived revenue of $18.2 million from two customers, with such customers accounting for 17% and 10% of the Company’s total revenue, respectively. The corresponding accounts receivable balances of customers from which revenues were in excess of 10% of total revenue were $9.4 million and $11.6 million at March 31, 2023 and 2022, respectively. International sales accounted for approximately 26% of the Company’s total revenue in each of the three months ended March 31, 2023 and 2022. For the six months ended March 31, 2023 and 2022, international sales accounted for approximately 24% and 29% of the Company’s total revenue, respectively. From a geographic perspective, approximately 70% and 69% of the Company’s total long-term assets as of March 31, 2023 and September 30, 2022, respectively, are associated with the Company’s international subsidiaries. From a geographic perspective, approximately 17% and 19% of the Company’s total long-term assets excluding goodwill and other intangible assets as of March 31, 2023 and September 30, 2022, respectively, are associated with the Company’s international subsidiaries.

X

- Definition

The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 275
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//275/tableOfContent

+ Details

Name:	us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RisksAndUncertaintiesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration